Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents
Molecules · 2023
DOI: 10.3390/molecules28093856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Valeria Stefanizzi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy. Hauptthemen laut MEDLINE: Trialkyltin Compounds, Antineoplastic Agents, Organotin Compounds, Coordination Complexes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research PRIN, Italian Ministry of University and Research, PRIN.
Abstract (Originalsprache)
Metal-derived platinum complexes are widely used to treat solid tumors. However, systemic toxicity and tumor resistance to these drugs encourage further research into similarly effective compounds. Among others, organotin compounds have been shown to inhibit cell growth and induce cell death and autophagy. Nevertheless, the impact of the ligand structure and mechanisms involved in the toxicity of organotin compounds have not been clarified. In the present study, the biological activities of commercially available bis(tributyltin) oxide and tributyltin chloride, in comparison to those of specially synthesized tributyltin trifluoroacetate (TBT-OCOCF3) and of cisplatin, were assessed using cells with different levels of tumorigenicity. The results show that tributyltins were more cytotoxic than cisplatin in all the tested cell lines. NMR revealed that this was not related to the interaction with DNA but to the inhibition of glucose uptake into the cells. Moreover, highly tumorigenic cells were less susceptible than nontumorigenic cells to the nonunique pattern of death induced by TBT-OCOCF3. Nevertheless, tumorigenic cells became sensitive when cotreated with wortmannin and TBT-OCOCF3, although no concomitant induction of autophagy by the compound was detected. Thus, TBT-OCOCF3 might be the prototype of a family of potential anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Science and Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.
- Ph.D. Course in Microbiology, Immunology, Infectious Diseases, and Transplants (MIMIT), University of Rome "Tor Vergata", 00133 Rome, Italy.
- Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
- Department of Chemistry Ugo Schiff, University of Florence, 50019 Florence, Italy.
- Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
- Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, 98166 Messina, Italy.
ORCID-Profile: Valeria Stefanizzi, Antonella Minutolo, Franca M Cordero, Daniel Oscar Cicero, Greta Petrella, Claudia Matteucci, Francesca Marino-Merlo, Antonio Mastino, Beatrice Macchi
Förderung
- Italian Ministry of University and Research PRIN
- Italian Ministry of University and Research, PRIN
Zitieren
APA
Stefanizzi, V., Minutolo, A., Valletta, E., Carlini, M., Cordero, F. M., Ranzenigo, A., Prete, S. P., Cicero, D. O., Pitti, E., Petrella, G., Matteucci, C., Marino-Merlo, F., Mastino, A., & Macchi, B. (2023). Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents. Molecules. https://doi.org/10.3390/molecules28093856
Vancouver
Stefanizzi V, Minutolo A, Valletta E, Carlini M, Cordero FM, Ranzenigo A, et al. Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents. Molecules. 2023. doi:10.3390/molecules28093856
BibTeX
@article{Stefanizzi2023,
author = {Stefanizzi, Valeria and Minutolo, Antonella and Valletta, Elena and Carlini, Martina and Cordero, Franca M and Ranzenigo, Anna and Prete, Salvatore Pasquale and Cicero, Daniel Oscar and Pitti, Erica and Petrella, Greta and Matteucci, Claudia and Marino-Merlo, Francesca and Mastino, Antonio and Macchi, Beatrice},
title = {Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28093856}
}
EUVIMED